Logos Global Management’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.1M | Sell |
1,000,000
-650,000
| -39% | -$15M | 2.56% | 11 |
|
|
2025
Q1 | $44.6M | Buy |
1,650,000
+400,000
| +32% | +$10.8M | 7.92% | 4 |
|
|
2024
Q4 | $66.9M | Buy |
1,250,000
+250,000
| +25% | +$13.4M | 7.83% | 2 |
|
|
2024
Q3 | $45.4M | Buy |
1,000,000
+250,000
| +33% | +$11.4M | 4.9% | 5 |
|
|
2024
Q2 | $31.4M | Buy |
750,000
+600,000
| +400% | +$25.1M | 2.53% | 11 |
|
|
2024
Q1 | $5.65M | Buy |
+150,000
| New | +$5.65M | 0.46% | 39 |
|
|
2022
Q1 | – | Sell |
-185,196
| Closed | -$3.65M | – | 57 |
|
|
2021
Q4 | $3.65M | Sell |
185,196
-61,926
| -25% | -$1.22M | 0.38% | 49 |
|
|
2021
Q3 | $4.81M | Sell |
247,122
-300,000
| -55% | -$5.84M | 0.35% | 42 |
|
|
2021
Q2 | $13.7M | Buy |
+547,122
| New | +$13.7M | 1.15% | 26 |
|